Mitochondria as targets for chemotherapy - PubMed (original) (raw)

Review

Mitochondria as targets for chemotherapy

Vladimir Gogvadze et al. Apoptosis. 2009 Apr.

Abstract

Mitochondrial malfunctioning is implicated in the pathogenesis of a variety of disorders, including cancer and multiple neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and Huntington's disease. Disturbance of mitochondrial vital functions, e.g., production of ATP, calcium buffering capacity, and generation of reactive oxygen species, can be potentially involved in disease pathogenesis. Neurological disorders caused by mitochondrial deterioration are often associated with cell loss within specific brain regions. In contrast, mitochondrial alterations in tumor cells and the "Warburg effect" might lead to cell survival and resistance of tumor cells to chemotherapy. This review is devoted to the role of mitochondria in neurodegeneration and tumor formation, and describes how targeting of mitochondria can be beneficial in the therapy of these diseases, which affect a large human population.

PubMed Disclaimer

Similar articles

• Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
  Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA. Calabrese V, et al. J Neurol Sci. 2005 Jun 15;233(1-2):145-62. doi: 10.1016/j.jns.2005.03.012. J Neurol Sci. 2005. PMID: 15896810 Review.
• Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
  Sas K, Robotka H, Toldi J, Vécsei L. Sas K, et al. J Neurol Sci. 2007 Jun 15;257(1-2):221-39. doi: 10.1016/j.jns.2007.01.033. Epub 2007 Apr 25. J Neurol Sci. 2007. PMID: 17462670 Review.
• Mitochondria take center stage in aging and neurodegeneration.
  Beal MF. Beal MF. Ann Neurol. 2005 Oct;58(4):495-505. doi: 10.1002/ana.20624. Ann Neurol. 2005. PMID: 16178023 Review.
• Reactive oxygen species: stuck in the middle of neurodegeneration.
  Patten DA, Germain M, Kelly MA, Slack RS. Patten DA, et al. J Alzheimers Dis. 2010;20 Suppl 2:S357-67. doi: 10.3233/JAD-2010-100498. J Alzheimers Dis. 2010. PMID: 20421690 Review.
• Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
  Calabrese V, Boyd-Kimball D, Scapagnini G, Butterfield DA. Calabrese V, et al. In Vivo. 2004 May-Jun;18(3):245-67. In Vivo. 2004. PMID: 15341181 Review.

Cited by

• Mitochondrial permeability transition pore as a selective target for anti-cancer therapy.
  Suh DH, Kim MK, Kim HS, Chung HH, Song YS. Suh DH, et al. Front Oncol. 2013 Mar 8;3:41. doi: 10.3389/fonc.2013.00041. eCollection 2013. Front Oncol. 2013. PMID: 23483560 Free PMC article.
• Efficacy of chlorin e6-mediated sono-photodynamic therapy on 4T1 cells.
  Li Q, Wang X, Wang P, Zhang K, Wang H, Feng X, Liu Q. Li Q, et al. Cancer Biother Radiopharm. 2014 Feb;29(1):42-52. doi: 10.1089/cbr.2013.1526. Epub 2013 Nov 9. Cancer Biother Radiopharm. 2014. PMID: 24206161 Free PMC article.
• The mitochondrial transport protein SLC25A43 affects drug efficacy and drug-induced cell cycle arrest in breast cancer cell lines.
  Gabrielson M, Tina E. Gabrielson M, et al. Oncol Rep. 2013 Apr;29(4):1268-74. doi: 10.3892/or.2013.2247. Epub 2013 Jan 23. Oncol Rep. 2013. PMID: 23354756 Free PMC article.
• Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy.
  Zhou Y, Jing S, Liu S, Shen X, Cai L, Zhu C, Zhao Y, Pang M. Zhou Y, et al. J Nanobiotechnology. 2022 Apr 12;20(1):188. doi: 10.1186/s12951-022-01392-y. J Nanobiotechnology. 2022. PMID: 35413984 Free PMC article.
• Mitochondria-Centric Review of Polyphenol Bioactivity in Cancer Models.
  Stevens JF, Revel JS, Maier CS. Stevens JF, et al. Antioxid Redox Signal. 2018 Dec 1;29(16):1589-1611. doi: 10.1089/ars.2017.7404. Epub 2017 Dec 11. Antioxid Redox Signal. 2018. PMID: 29084444 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information